MAUNA KEA TECHNOLOGIES |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.396 EUR | -0.25% |
|
+0.51% | -15.92% |
| Apr. 03 | Mauna Kea: first Italian center for Cellvizio | CF |
| Mar. 27 | Mauna Kea Technologies Partners with V7 to Develop Innovative AI Applications with Cellvizio | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Mauna Kea Technologies specializes in designing, developing, and selling optical biopsy devices and tools. The group's products are intended for visualizing and detecting cellular abnormalities during the gastrointestinal and pulmonary endoscopic procedures, primarily in cancer patients. Net sales break down by activity as follows:
- sales of accessories (41.9%): mini-probes, software, etc.;
- sales of system (39.8%);
- services (18.3%).
Net sales are distributed geographically as follows: the United States and Canada (56.2%), Asia/Pacific (5.4%), Europe-Middle East-Africa and other (38.4%).
Calendar
2024-04-24
- Q1 2024 Sales and Revenue Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.396
EUR
Average target price
1.955
EUR
Spread / Average Target
+393.69%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -15.92% | 25.99M | |
| -43.76% | 2.82B | |
| +7.25% | 1.78B | |
| -7.99% | 1.56B | |
| +29.09% | 1.25B | |
| -13.75% | 1.01B | |
| -23.36% | 900M | |
| -3.39% | 741M | |
| -15.12% | 701M | |
| +2.36% | 485M |
- Stock Market
- Equities
- ALMKT Stock
- News Mauna Kea Technologies
- Mauna Kea Technologies Plans to Move Listing to Euronext Growth Paris
